Hansard Global plc Stock Börse Stuttgart
Stocks
H9G
IM00B1H1XF89
Life & Health Insurance
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5900 EUR | -1.67% |
|
+0.59% | +0.59% |
| 07-17 | WINNERS & LOSERS: Itaconix revenue rises; Alumasc suspends CEO | AN |
| 03-20 | Hansard Global receives £2.1 mln from insurers for legacy litigation costs | RE |
| Market Cap | 71M 96.01M 83.12M 77.69M 134M 9.16B 136M 911M 357M 4.58B 361M 353M 15.26B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 71M 96.01M 83.12M 77.69M 134M 9.16B 136M 911M 357M 4.58B 361M 353M 15.26B | EV / Sales 2026 * |
0.76x | EV / Sales 2027 * | 0.69x |
| Free-Float |
45.51% | Yield 2026 * |
8.56% | Yield 2027 * | 8.56% |
| 1 week | +3.45% | ||
| Current month | +1.69% | ||
| 1 month | -0.83% | ||
| 3 months | +5.26% | ||
| 6 months | +1.69% | ||
| Current year | +21.46% |
| 1 week | 0.54 |  | 0.6 |
| 1 month | 0.54 | | 0.66 |
| 3 years | 0.42 | | 0.66 |
| 5 years | 0.37 | | 0.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Morfett
CEO | Chief Executive Officer | - | 02/08/2024 |
Ollie Byrne
DFI | Director of Finance/CFO | - | 01/10/2024 |
John Whitehouse
COO | Chief Operating Officer | - | 01/07/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Marc Polonsky
BRD | Director/Board Member | - | 26/09/2018 |
Philip Kay
CHM | Chairman | 70 | 01/05/2022 |
Ollie Byrne
BRD | Director/Board Member | - | 01/10/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.67% | +0.59% | +14.29% | +38.89% | 96.01M | |
| -3.06% | -4.49% | +23.86% | +114.85% | 143B | |
| -0.39% | -1.16% | +53.99% | +121.17% | 55.78B | |
| +3.31% | +3.76% | -10.41% | +23.06% | 52.13B | |
| -3.29% | -0.04% | +60.89% | +124.69% | 40.17B | |
| -1.21% | -3.69% | +26.05% | +121.15% | 23.77B | |
| -0.94% | -3.23% | -0.72% | +40.11% | 19.51B | |
| 0.00% | +2.14% | +101.03% | +150.88% | 16.33B | |
| -3.18% | -2.46% | +24.76% | +113.52% | 14.6B | |
| -0.79% | -1.14% | +30.75% | +58.83% | 14.08B | |
| Average | -1.05% | +1,097.94% | +32.45% | +90.72% | 42.15B | |
| Weighted average by Cap. | -1.37% | +613.98% | +29.98% | +100.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 93.06M 126M 109M 102M 175M 12B 178M 1.19B 469M 6B 472M 462M 20B | 102M 138M 120M 112M 193M 13.2B 196M 1.31B 515M 6.6B 520M 508M 22B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Life & Health Insurance
Calendar
| Date | Price | Change |
|---|---|---|
| 11/08/26 | €0.5900 | -1.67% |
| 10/08/26 | €0.6000 | 0.00% |
| 07/08/26 | €0.6000 | +1.69% |
| 06/08/26 | €0.5900 | 0.00% |
| 05/08/26 | €0.5900 | 0.00% |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5200GBP
Average target price
0.6500GBP
Spread / Average Target
+25.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HSD Stock
- H9G Stock
Select your edition
All financial news and data tailored to specific country editions
